Research Topic

Study examines risk of multiple sclerosis among users of antitumour necrosis factor alpha biologics in four Canadian provinces

Jennifer Gunville, 30, is among the 51% of nursing students in the province who took the September exam and failed to get the minimum passing grade—55%.

The study, which was published in Cell, is the largest whole genome sequencing study for autism in the world.

Neighbourhood Pharmacies and IQVIA team up to provide quantitative data report on the real value of pharmacy specialty services.

A recent study found the drug combination lenalidomide + rituximab is a durable, effective and safe alternative to the standard regimen combining rituximab and chemotherapy.

The guideline is an update to a 2018 iteration and adds 48 fresh recommendations.

Study from Spain finds a 47% reduced risk over time.

The treatment is approved for patients who have a moderate to high risk of recurrence, following nephrectomy or nephrectomy accompanied by surgical resection of metastatic lesions.